Member Info for Dartron

I have been adding to the ones that have already reported, as I see the risk is gone. I am amazed the shorts are able to sell this right now, when most people on here have already bought enough and are having second thoughts. Stas I use IG.

Agree Stas. I checked somewhere else and prints as you say. I will have to look in to why the L2 platform shows it as T. I have often made the assumption I stated below when I saw a T trade.

The trade at 15.34 - 1009983 shares at £3.20, is market as 'T' on my level 2 platform. That basically means it is a transfer (not a buy or a sell). It could be for multiple reasons, but in this situation I would guess that it is short stock being transferred one way or the other. (*or maybe voting rights like Fidelity do here?) Its funny, they always seem a little over the ask. It is about 0.8% of the company - larger than any individual short. If that had been a buy, I think the price would have moved much higher.

Stas said that Jupiter Asset Management Ltd took over from Jupiter Investment Management Limited. If the former had a small short under the FCA limit, then upon taking the latter the position would look bigger. Good spot Stas.

I still hold shares here and a very small spread bet. I must say if shorts are not covering, then they are expecting some bad news. I have also had several companies report with 'ok' numbers and still get hammered by shorts. I cant see You reporting anything better than 'ok'. I would buckle up - could be in for a rough ride. Take Spire health care, it has been hammered to almost less than book value (owning a lot of property) by GLG. Once it crashed to 170p (which was low) they then increased the short. That says they think there could be more down side. I think when YOU was £4.30 last year nobody thought it would go lower and look where we are.

Im not bothered about my pension holding - once we know where the lay of land is, I may add some more. It will be alright eventually. The Spreadbet, well you can make plenty of money on the volatility if the shorts get lively.

Though as I said, I been trading the S&P and Russel - its so much easier, quicker and more profitable. Think about it, this stock has barely moved for nearly a month. Cant make money on it, but the S&P dropped in the morning, rose in the afternoon and dropped in the evening. 3 pay outs and no AIM bullsh*t.

I have been thinking the same, hopefully some trading update with the results, as the results are old news now 12 months ended 31 December 2024.

Managed to close a small position which was a trade, for little over break even. Shorts have increased again..

I dont hold this at all now, except with exposure via an investment trust. I wouldnt buy until after results.

Someone made a good point on the other board, saying that if they left Aim they would be close to the F250. Then you would get the trackers buying (dont know if Octopus would then sell and it would net out?).

Health care is really unloved at the moment. GLG are short on several health care stocks including this one. They control the price IMO.

I have often wondered what warranted such a large short position here, spread across multiple firms. Perhaps the valuation is a little lofty, but this mornings trading update seems to put any concerns to bed. What is more, whilst these firms have sold this stock short, Coronation fund managers have been buying it, up at 11%. Perhaps this really is one that the shorts have got wrong. I shall be adding to my position.

The Group once again delivered double-digit growth in its key financial metrics, gross invoiced income, gross profit and operating profit, demonstrating the strength of our business model and market positioning. Gross invoiced income comfortably exceeded £2 billion for the first time, marking a significant milestone. Moreover, operating profit grew in the mid-to-high-teens, underscoring our continued momentum. We are particularly pleased with the acceleration in gross profit growth in the second half, which was balanced across both corporate and public sector clients, to deliver full year growth of around 12%. Cash conversion remained strong for FY25, surpassing the Group's target of 100%, with a cash balance of over £110m at year end.

Represents a positive valuation revision of £16.7m compared to its last published carrying value of £2.8m as of 30 September 2024. The overall impact on the Company's net asset value will be evaluated as part of the Company's 31 March 2025 net asset value publication.

Not bad!

8p FFS

This has been the only share I have sold at a considerable loss this year (24.5p). It has actually turned out to be about my best decision so far this year. I just looked at Renx, it didnt take long to reach a conclusion. Im not good at taking losses, but I feel very happy with my decision 1 month on, (as you usually do in these situations). I shudder to think what might get announced at the London press conference on the 25th (note the dual event is after both sets of results. The London event is in the evening after the investor meet in the day - after market is closed, though might be an RNS on the day).

Shotgun wedding!

EKF management will provide an in-person presentation relating to the Company's final results at 5.30pm on Tuesday 25 March 2025, which is open to all existing and potential shareholders. The Company welcomes investors to 75 King William Street, London, EC4N 7BE from 5.15pm for a 5.30pm start and will be followed by refreshments.

I dont like the sound of a demerger with 2 listings. The problem he is trying to solve is that the publics markets do not value the company. Increasing the paper will not help, in fact it will double costs. Hornby talking about de listing today say it will save them 400k not being listed. Why would we want 2 x that cost. 2 CEO's etc. It almost sounds like no on else wants us so they do that to look like they are solving a problem. In that case, keep it as one, sort the company out, and increase shareholder value by the traditional purpose of being listed. Grow your earnings and distribute profits.

No idea why he paid for that interview.

Agree unhooked and SB. Virtually impossible to make money on small caps. And yes it could all be irrelevant in the future.

I have not added to my pension this tax year, only 1 month to go. I have the cash saved up, but why give it to a hedge fund. Im tempted to take a year out now, and actually see some benefit from my savings. Not much work out there either.

on EKF, its not really any worse than other shares. I expect they are affected by tariffs. The market hates health shares, and EKF is a dud, so trading as expected.

Cheers, I took the data from the TIG web page

https://teaminternet.com/major-shareholders/

So what. If we look at your posts, your just a dip buyer. I mean, you even ramped that building products thing that was delisting, I forget the name. The difference is that your just hoping it will go up. I have stated facts. I think they would be better off not doing the buy back, but you wont like that as it jeopardises your liquidity.

Perhaps some of the rampant bulls should have a think about the buy backs. The company had 99M debt in Sep24, and up to that point had spent $13.8M on buy backs in the financial year (shares around 1.30p). You could say the $13.8M has been wasted buying something that is now worth under half that price. Then we had price crash no1 and the company (has not released official figures) but at the time, I tallied up at least £2.5M spent on buy backs at 80p to 105p, again this money has now been wasted somewhat. To top it all, we still have 99M of debt (last reported).

So not only have the BOD made a poor acquisition - Shinez, but they have also wasted at least half as much again buying back stock that has halved. I am genuinely intrigued to see if the CEO is able to keep his job come the AGM at the end of the month. I am also wondering what Kestrels next move could be, because Kestrel only own 23%. I would be more concerned that they are not buying stock. I do think 60p is about right currently, which may be one reason they are not buying. Perplexing, but one thing is for sure, CEO Michael Riedl and CFO Billy Green have a lot of explaining to do.

With the debt, the EV here is currently £219M. The ebitda forecast is £50M (taking the value in the middle of their guidance) so this is looking about fair for now, 4.5 times for a company that cant get much right. On that basis, they ought to stop the buy backs (which is only massaging the EPS and assisting Kestrel to own more and more of it), and focus on debt reduction and perhaps a strategic review, since it appears they have hit a brick wall, or should I say had hit a brick wall in early 2024.

Annual report for the financial year ended 31 December 2024 on Monday, 24 March 2025. Are we going to see more dirty laundry on that day?

Tom, I just trade the index. Long the Russel small cap, and have been in and out of the SP500 eqiv on IG. I did also buy some L&G Russel ETF today for pension. (https://www.lse.co.uk/SharePrice.html?shareprice=RTWP&share=Lg-Rus2000-Qual)

The liquidity is so much better, I can make what im down here in 1 hr. Tempted to can this and stick to futures.

As soon as the US opened (and started down) this followed. It just shows people are happy to sell this, I am becoming less optimistic about this bouncing. Meanwhile, I bought the US for a recovery bounce, why bother with stale AIM stocks.

On that note, the media article about someone buying AIM. FFS. I kid you not.

https://www.msn.com/en-ie/money/other/group-of-investors-ready-to-make-offer-to-buy-under-fire-aim-market/ar-AA1AEHJR

Disgraceful there was so much selling last week.

Must be about time for them to tell us what the NAV was 3 months ago?

Simon Thompson recommending this in IC this week.

I think I bought this off one of his tips before, wasn't it a 10% yield at one point.